The Saltzman family, a well-known South African billionaire family, has seen the market value of its interest in Dis-Chem Pharmacies fall by $44.1 million as a result of the company’s recent share price dip on the Johannesburg Stock Exchange (JSE).
The market value of the Saltzman family’s holding in Dis-Chem Pharmacies has fallen by R839.74 million ($44.1 million) in the last 27 days, demonstrating a shift in investor sentiment on the JSE.
Dis-Chem Pharmacies, a leading South African retail pharmacy and healthcare firm, has been a strong presence in the healthcare market for almost four decades, dating back to its foundation by Lynette and Ivan Saltzman.
The firm provides a diverse range of services, including dispensaries, family clinics, wound care clinics, and full self-medication centers.
Dis-Chem Pharmacies’ shares on the JSE have fallen 7.31 percent in the last 27 days, from R33.81 (R1.78036) on March 22 to R31.03 (R1.6503). This has reduced the market value below R1.5 billion, resulting in significant losses for stockholders.
Lynette and Ivan Saltzman own a sizable 35.12 percent share in the Gauteng-based healthcare firm. Under their leadership, the company has expanded into one of Africa’s largest retail pharmacy chains, with over 300 locations and more than 20,000 employees.
The family’s total investment has decreased by R839.74 million ($44.12 million) over the last 27 days, from R10.21 billion ($536.54 million) on March 22 to R9.37 billion ($492.42 million) today.
Despite their collapse, the Saltzmans remain major investors on the Johannesburg Stock Exchange (JSE), with a long-term impact on South Africa’s healthcare and pharmacy retail sector.
